As humanity edges closer to mining the moon, industry analysts warn that established mining companies, not venture-backed space startups, may dominate the emerging lunar resource sector. The space…
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure…
John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices and stocks. He also speaks ‘special situation’ companies. ‘(There’s) a change…